Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers.
about
Advances in pediatric pharmacology, therapeutics, and toxicology.Population pharmacokinetics of abacavir in pregnant women.Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors.Population pharmacokinetics of abacavir in infants, toddlers and children.Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662.
P2860
Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Population pharmacokinetics an ...... infected infants and toddlers.
@ast
Population pharmacokinetics an ...... infected infants and toddlers.
@en
type
label
Population pharmacokinetics an ...... infected infants and toddlers.
@ast
Population pharmacokinetics an ...... infected infants and toddlers.
@en
prefLabel
Population pharmacokinetics an ...... infected infants and toddlers.
@ast
Population pharmacokinetics an ...... infected infants and toddlers.
@en
P2093
P2860
P1476
Population pharmacokinetics an ...... infected infants and toddlers.
@en
P2093
David Burger
Massimo Cella
Oscar Della Pasqua
Pediatric European Network for Treatment of AIDS (PENTA) 15 study group
P2860
P304
P356
10.1111/J.1365-2125.2011.04121.X
P407
P577
2012-04-01T00:00:00Z